Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

READCELL

Financiado

Cerrado

System for the efficient and non invasive harvesting and RElease of ADherent CEL...

System for the efficient and non invasive harvesting and RElease of ADherent CELLs controlled by light The Biopharmaceuticals market is currently valued at about 150,000 million euros with an annual growth rate of 6 %. Biopharmaceutical products are mainly obtained from cells cultured in contained systems. Adherent cells represent... ver más

31/10/2017

ASOC CENTRO DE INV...

150K€

Presupuesto del proyecto: 150K€

Líder del proyecto

ASOC CENTRO DE INVESTIGACION COOP EN BIO No se ha especificado una descripción o un objeto social para esta compañía.

TRL 3-4 | 6M€

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2017-10-31

ERC-PoC-2015: ERC Proof of Concept Grant

I+D

Cerrada hace 9 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

ASOC CENTRO DE INVESTIGACION...

149.94K€ | Lider

SPINREACT

267.22K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

Facer The First Cell Culture Platform that Enables Affordable Cell... 2M€ Cerrado

AGLARIS AGLARIS The First Fully automated Bioreactor for Large Scal... 71K€ Cerrado

AUTOSTEM Development of closed scalable and AUTOmated robotic system... 6M€ Cerrado

PTQ-11-05016 Desarrollo nuevos sistemas de cultivo in vitro para la produ... 70K€ Cerrado

SMARTER Smart manufacturing for autologous cell therapies enabled by... 1M€ Cerrado

Multiscreen Multiple cellular screens using microfluidic droplets 150K€ Cerrado

Duración del proyecto: 18 meses Fecha Inicio: 2016-04-23
Fecha Fin: 2017-10-31

Líder del proyecto

ASOC CENTRO DE INVESTIGACION COOP EN BIO No se ha especificado una descripción o un objeto social para esta compañía.

TRL 3-4 | 6M€

Presupuesto del proyecto 150K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The Biopharmaceuticals market is currently valued at about 150,000 million euros with an annual growth rate of 6 %. Biopharmaceutical products are mainly obtained from cells cultured in contained systems. Adherent cells represent an important share of the cell types used in production processes and are the major source of cell therapy products. Productivity of current processes for adherent cells culture lags behind those based on suspension cells and the reasons for this imbalance are to be found mainly on the low volumetric productivity and automation of current processes for adherent cells culture. Recovery of cells from the surface they are attached to, the so-called cell harvest is commonly performed by disrupting the interaction of the cells with the support by manually introducing hydrolyzing enzymes into the culture device. These enzymes attack the cell at the adhesion point driving them into suspension for further recovery. Due to the manual nature of the cell harvest step, the exposure of cells to the external environment during the enzymatic treatment and the harsh biochemical conditions, this is one of the least efficient steps in the production process and poses an important risk of damaging and contaminating the culture. The idea proposed in this project for Proof of Concept will turn the cell harvest step into an automated, non-invasive and efficient step in the cell culture process. To achieve this goal we will introduce nanostructured modifications in the cell culture support by immobilising gold nanoparticles of defined size and shape, in certain geometrical patterns. The resulting cell culture support interacts with low energy electromagnetic radiation coming from an external and non-invasive source, creating localised hyperthermal effects at the locations of the immobilized nanoparticles and leading to the release of growing cells. Results of successful preliminary experiments are the basis of a recently submitted patent application.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores